A National Registry For Pulmonary Alveolar Proteinosis | MicrobiomeTrials← Back to trialsNCT02461615
A National Registry For Pulmonary Alveolar Proteinosis
RecruitingOBSERVATIONAL
Trial Details
Start: 2015-04Est. Completion: 2030-12
Enrollment target: 500 participants Locations- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Other microbiome trials you might be interested in
Autoimmune Pulmonary Alveolar Proteinosis
Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare disorder in which a material called surfactant builds up in t…
Los Angeles, United States
Pulmonary Alveolar Proteinosis (PAP)Severe Mucocutaneous Candidiasis
Background:
* Healthy people have white blood cells that protect them against bacteria, viruses, and fungi. However, so…
Bethesda, United StatesCompleted May 6, 2021
Pulmonary Alveolar Proteinosis (PAP)MARSGenetic Mutation
Mutations in the MARS gene encoding methionyl-tRNA synthetase are responsible for a genetic form of alveolar proteinosis…
Paris, FranceCompleted Nov 6, 2021